|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-12-5
|
|
pubmed:abstractText |
Neuropsychological testing and 2 measures of neurological status, cortical atrophy, and motor dysfunction were assessed for their usefulness in predicting human immunodeficiency virus (HIV) disease progression in infants, children, and adolescents who participated in Pediatric AIDS Clinical Trials Group Protocol 152 (PACTG 152).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1098-4275
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
106
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
E76
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11099619-AIDS Dementia Complex,
pubmed-meshheading:11099619-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:11099619-Adolescent,
pubmed-meshheading:11099619-Anti-HIV Agents,
pubmed-meshheading:11099619-Brain,
pubmed-meshheading:11099619-CD4 Lymphocyte Count,
pubmed-meshheading:11099619-Child,
pubmed-meshheading:11099619-Child, Preschool,
pubmed-meshheading:11099619-Didanosine,
pubmed-meshheading:11099619-Disease Progression,
pubmed-meshheading:11099619-Double-Blind Method,
pubmed-meshheading:11099619-Drug Therapy, Combination,
pubmed-meshheading:11099619-Female,
pubmed-meshheading:11099619-HIV-1,
pubmed-meshheading:11099619-Humans,
pubmed-meshheading:11099619-Infant,
pubmed-meshheading:11099619-Intelligence Tests,
pubmed-meshheading:11099619-Male,
pubmed-meshheading:11099619-Neurologic Examination,
pubmed-meshheading:11099619-Neuropsychological Tests,
pubmed-meshheading:11099619-Predictive Value of Tests,
pubmed-meshheading:11099619-RNA, Viral,
pubmed-meshheading:11099619-Regression Analysis,
pubmed-meshheading:11099619-Zidovudine
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS clinical trials 152 study team.
|
|
pubmed:affiliation |
Department of Psychiatry and Behavioral Sciences, University of Texas-Houston Medical School, Houston, Texas, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
